8-K: Kimberly-Clark Exceeds Expectations in Q2 2024, Raises Full-Year Outlook

Kimberly-Clark reported strong second-quarter results, driven by organic sales growth and effective cost management, leading to an increased full-year earnings outlook.

Summary

• Kimberly-Clark's second-quarter 2024 net sales reached $5.0 billion, a 2 percent decrease compared to the prior year, but organic sales grew by 4 percent.
• The company's adjusted gross margin increased to 36.9 percent, a 290 basis point improvement year-over-year, due to organic sales growth and productivity gains.
• Diluted earnings per share were $1.61, while adjusted earnings per share rose 19 percent to $1.96, despite a $0.12 headwind from currency translation.
• Organic sales growth was driven by a 2 percent increase in price and a 2 percent increase from volume and mix.
• The company's year-to-date sales were $10.2 billion, a 1 percent decrease, but organic sales grew 5 percent.
• Kimberly-Clark has raised its full-year 2024 outlook, now expecting adjusted operating profit and adjusted earnings per share to grow at a mid-to-high teens percentage rate on a constant-currency basis.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong organic sales growth, improved margins, and an increased full-year outlook. While there are some negative impacts from currency and divestitures, the overall tone is optimistic.

Positives

• Organic sales growth of 4 percent in Q2 and 5 percent year-to-date indicates strong demand for Kimberly-Clark's products.
• The 290 basis point increase in adjusted gross margin demonstrates effective cost management and productivity improvements.
• The 19 percent increase in adjusted earnings per share shows strong profitability.
• The company's raised full-year outlook suggests confidence in continued performance.
• The Personal Care segment showed strong organic sales growth of 8 percent.
• Cash provided by operations increased to $1.5 billion year-to-date.

Negatives

• Reported net sales decreased by 2 percent in Q2 and 1 percent year-to-date due to currency translation and divestitures.
• The Consumer Tissue segment experienced a 2 percent decline in organic sales.
• The K-C Professional segment had flat organic sales.
• Unfavorable currency translation had a negative impact on reported results.
• The company incurred $190 million in costs related to its 2024 Transformation Initiative in Q2 and $235 million year-to-date.

Risks

• Currency translation continues to negatively impact reported results, particularly in hyperinflationary economies.
• Input cost inflation, especially in Developing and Emerging markets, could pressure margins.
• Supply chain related investments and planned increases in marketing, research and general expenses could impact profitability.
• The company's 2024 Transformation Initiative involves costs and potential disruptions.
• The company is exposed to risks related to war in Ukraine, pandemics, and other global economic and political conditions.

Future Outlook

Kimberly-Clark has raised its full-year 2024 outlook, now expecting adjusted operating profit and adjusted earnings per share to grow at a mid-to-high teens percentage rate on a constant-currency basis. Reported net sales are still expected to be negatively impacted by 400 basis points of currency translation and 120 basis points from divestitures.

Management Comments

• We have made strong progress while navigating dynamic consumer and retail environments, said Kimberly-Clark Chairman and CEO Mike Hsu.
• Our focus is to deliver high-quality consumer solutions at every price point, increase our operational scale, and enhance our long-term potential.

Industry Context

Kimberly-Clark's results reflect a broader trend in the consumer goods industry where companies are focusing on innovation, cost management, and productivity to drive growth in a challenging economic environment. The company's focus on pricing and volume mix is consistent with strategies employed by other major players in the sector.

Comparison to Industry Standards

• Procter & Gamble (PG) reported a 3% increase in organic sales in their most recent quarter, while Kimberly-Clark reported 4% organic growth, indicating a strong performance relative to a key competitor.
• Colgate-Palmolive (CL) reported a gross margin of 58.5% in their most recent quarter, while Kimberly-Clark's adjusted gross margin was 36.9%, suggesting that Kimberly-Clark has room for improvement in this area.
• Kimberly-Clark's adjusted EPS growth of 19% is strong compared to the average growth rate of the consumer staples sector, which is typically in the single-digit range.
• The company's focus on productivity gains and cost management is in line with industry best practices, as companies seek to improve profitability in the face of rising input costs.

Stakeholder Impact

• Shareholders will benefit from the increased earnings and positive outlook.
• Employees may experience changes due to the 2024 Transformation Initiative.
• Customers will benefit from the company's focus on delivering high-quality consumer solutions.
• Suppliers may be impacted by the company's supply chain investments.

Next Steps

• The company will continue to focus on its 2024 Transformation Initiative.
• Kimberly-Clark will host a live Q&A session with investors and analysts on July 23, 2024.
• The company will continue to monitor and adapt to the macro environment.

Key Dates

Keywords

Kimberly-Clark, organic sales growth, earnings per share, gross margin, transformation initiative, consumer products, personal care, consumer tissue, K-C Professional, financial results